The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells
Tumor tissue biopsy is often limited for non-small cell lung cancer (NSCLC) patients and alternative sources of tumoral information are desirable to determine molecular alterations such as anaplastic lymphoma kinase (ALK) rearrangements. Circulating tumor cells (CTCs) are an appealing component of l...
Main Authors: | Arutha Kulasinghe, Yenkai Lim, Joanna Kapeleris, Majid Warkiani, Ken O’Byrne, Chamindie Punyadeera |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/6/1465 |
Similar Items
-
From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)
by: Michael T. Werner, et al.
Published: (2017-10-01) -
Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets
by: Arutha Kulasinghe, et al.
Published: (2019-03-01) -
ALK Positive Anaplastic Large Cell Lymphoma Presenting as Extensive Bone Involvement
by: Smeeta Gajendra, et al.
Published: (2015-01-01) -
The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
by: Brandon Golding, et al.
Published: (2018-02-01) -
Anaplastic large cell lymphoma ALK-negative clinically mimicking alcoholic hepatitis – a review
by: Fernando Peixoto Ferraz de Campos, et al.
Published: (2013-10-01)